Table 1.
Baseline Characteristic | Subjects with PGDM (n = 22,331) |
Subjects with GDM (n = 147,097) |
p-value |
---|---|---|---|
n (prevalence) | n (prevalence) | ||
Age (years) | <.001 | ||
15–19 | 545 (2.44%) | 2495 (1.70%) | |
20–24 | 2684 (12.02%) | 15,273 (10.38%) | |
25–29 | 4897 (21.93%) | 33,237 (22.60%) | |
30–34 | 6352 (28.44%) | 46,500 (31.61%) | |
35–39 | 5729 (25.65%) | 38,327 (26.06%) | |
40–44 | 1996 (8.94%) | 10,556 (7.18%) | |
45+ | 128 (0.57%) | 709 (0.48%) | |
Advanced Maternal Age (≥35 years) | 7853 (35.17%) | 49,592 (33.71%) | <.001 |
Race/Ethnicity | <.001 | ||
Caucasian | 6791 (30.41%) | 45,348 (30.83%) | |
Black | 1478 (6.62%) | 4815 (3.27%) | |
Native American/Eskimo/Aleut | 61 (0.27%) | 196 (0.13%) | |
Asian/Pacific Islander | 1574 (7.05%) | 20,814 (14.15%) | |
Hispanic | 12,427 (55.65%) | 75,924 (51.61%) | |
Hypertensive disease present | 4038 (18.08%) | 11,547 (7.85%) | <.001 |
Private insurance | 10,045 (45.12%) | 77,095 (52.59%) | <.001 |
PGDM: Pre-gestational diabetes.
GDM: Gestational diabetes.